These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27298657)

  • 1. Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.
    Martinez-Orozco FJ; Vicario JL; De Andres C; Fernandez-Arquero M; Peraita-Adrados R
    J Clin Med Res; 2016 Jul; 8(7):495-505. PubMed ID: 27298657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcolepsy with cataplexy and comorbid immunopathological diseases.
    Martínez-Orozco FJ; Vicario JL; Villalibre-Valderrey I; De Andrés C; Fernández-Arquero M; Peraita-Adrados R
    J Sleep Res; 2014 Aug; 23(4):414-9. PubMed ID: 24645699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases.
    Martinez-Orozco FJ; Fernandez-Arquero M; Vicario JL; Lillo-Triguero L; Ameyugo E; Peraita-Adrados R
    J Clin Med Res; 2022 Aug; 14(8):309-314. PubMed ID: 36128006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    Curr Treat Options Neurol; 2016 Oct; 18(10):43. PubMed ID: 27549768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-mediated comorbidities in Saudi patients with narcolepsy.
    Alomar M; Almeneessier AS; Olaish AH; Alshiban A; Alomar A; BaHammam AS
    Nat Sci Sleep; 2019; 11():35-43. PubMed ID: 31118849
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Monaca C; Franco P; Philip P; Dauvilliers Y
    Rev Neurol (Paris); 2017; 173(1-2):25-31. PubMed ID: 27838095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcolepsy with cataplexy and hyperthyroidism sudden appeared after H1N1 vaccination.
    Leiva S; Madrazo J; Podesta C
    Sleep Sci; 2018; 11(1):34-36. PubMed ID: 29796199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
    Ruoff C; Rye D
    Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ullanlinna Narcolepsy Scale in diagnosis of narcolepsy.
    Sarkanen T; Alakuijala A; Partinen M
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30476331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
    Dauvilliers Y; Lopez R
    Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.
    Pizza F; Barateau L; Jaussent I; Vandi S; Antelmi E; Mignot E; Dauvilliers Y; Plazzi G;
    Neurology; 2019 Sep; 93(11):e1034-e1044. PubMed ID: 31405906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narcolepsy in Slovakia - Epidemiology, clinical and polysomnographic features, comorbid diagnoses: a case-control study.
    Feketeova E; Tormasiova M; Klobučníková K; Durdik P; Jarcuskova D; Benca M; Vitkova M
    Sleep Med; 2020 Mar; 67():15-22. PubMed ID: 31884306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy during Childhood: An Update.
    Rocca FL; Pizza F; Ricci E; Plazzi G
    Neuropediatrics; 2015 Jun; 46(3):181-98. PubMed ID: 25961600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of narcolepsy.
    Miyagawa T; Tokunaga K
    Hum Genome Var; 2019; 6():4. PubMed ID: 30652006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.